Copyright
©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Feb 14, 2005; 11(6): 785-790
Published online Feb 14, 2005. doi: 10.3748/wjg.v11.i6.785
Published online Feb 14, 2005. doi: 10.3748/wjg.v11.i6.785
Figure 1 Inhibition of telomerase activity by telomerase ASODN.
A: The relative telomerase activity (% control) of SW480 cells transfected with 0.2 µmol/L ASOND for 24, 48, 72 h respectively. Extracts of SW480 cell were quantified with a TRAPEZE® ELISA telomerase detection kit. Sensitivity of telomerase PCR-ELISA (mean±SD of three experiments). B: Telomerase activity (% control) of SW480 cells transfected by ASODN with various concentrations for 72 h. The concentration of ASODN was 0.05, 0.1, 0.2 µmol/L, respectively (mean±SD of three experiments). C: PAGE figure of TRAP-PCR: Lane 1, Oligofectamine; lane 2, S-hTR; lane 3, anti-hTR; lane 4, anti-hTERT; lane 5: S-hTERT; lane 6, control; lane 7, anti-hTR+anti-hTERT; lane 8, negative; ITAS was the 36-bp internal control. Negative was lysis buffer.
- Citation: Fu XH, Zhang JS, Zhang N, Zhang YD. Combination of telomerase antisense oligonucleotides simultaneously targeting hTR and hTERT produces synergism of inhibition of telomerase activity and growth in human colon cancer cell line. World J Gastroenterol 2005; 11(6): 785-790
- URL: https://www.wjgnet.com/1007-9327/full/v11/i6/785.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i6.785